Latest news
UPDATE - CurePSP Announces Enrollment of First Participant in the PSP Trial Platform - lincolnjournal.comlincolnjournal.com · Fri, 07 Aug 2026 16:16:16 GMTCurePSP Announces Enrollment of First Participant in the PSP Trial Platform - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:00:00 GMTRactigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:56:14 GMTModerna vaccine trial aimed at international Ebola outbreak begins in Nova Scotia - PNI Atlantic NewsPNI Atlantic News · Wed, 05 Aug 2026 21:04:54 GMTBioAge Labs Reports Q2 2026 Results, Doses First Patient in QUELL-CV and Advances BGE-102 Clinical Development - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 21:01:00 GMTNovartis Enrolled First Participant in Phase 3 PRESERVE Clinical Trial for Experimental PSP-RS Treatment - AFTD - The Association for Frontotemporal DegenerationAFTD - The Association for Frontotemporal Degeneration · Wed, 05 Aug 2026 13:00:45 GMTFDA Names Its First Company in a Pilot That Lets Some Digital Health Devices Skip Premarket Review - Medical DailyMedical Daily · Mon, 03 Aug 2026 18:00:39 GMTModerna’s Bundibugyo ebolavirus vaccine candidate enters first human trial, backed by CEPI - CEPICEPI · Mon, 03 Aug 2026 07:00:00 GMT